ACM Biolabs Pte Ltd is rated 3 out of 5 in the category biotechnology. Read and write reviews about ACM Biolabs Pte Ltd. At ACM Biolabs, we are focused on developing novel vaccines and antibodies using our proprietary artificial cell membrane ("ACM") technology. We are able to incorporate functional, folded membrane proteins into the artificial cell membranes which keep them stable, allowing them to induce a strong immune reaction. We have demonstrated efficacy via both injected and oral dosages using synthesized membrane proteins and have a growing pipeline of vaccine and antibodies. The company is headquartered in Singapore, and has been operational since 2013.
Company size
11-50 employees
Headquarters
Singapore, Singapore